Sections
| Title | Starting Page | Number of Pages |
|---|
| Table of Contents | 2 | 4 |
| List of Tables | 4 | 1 |
| List of Figures | 5 | 1 |
| Bristol-Myers Squibb Company, Medical Equipment, Deals By Year, 2010 to YTD 2016 | 5 | 2 |
| Bristol-Myers Squibb Company, Medical Equipment Deals By Type, 2010 to YTD 2016 | 7 | 1 |
| Bristol-Myers Squibb Company, Medical Equipment, Deals By Region, 2010 to YTD 2016 | 8 | 1 |
| Bristol-Myers Squibb Company, Medical Equipment, Deals By Market, 2010 to YTD 2016 | 9 | 1 |
| Bristol-Myers Squibb Company, Medical Equipment, Deals Summary, 2010 to YTD 2016 | 10 | 2 |
| Bristol-Myers Squibb Company, Medical Equipment, Deal Details | 12 | 21 |
| Partnerships | 12 | 1 |
| HTG Molecular Diagnostics Enters into Research Agreement with Bristol-Myers Squibb | 12 | 1 |
| SomaLogic Enters into Agreement with Bristol-Myers Squibb | 13 | 1 |
| Leica Biosystems Enters into Co-Development Agreement with Bristol-Myers Squibb | 14 | 1 |
| InCell Enters Into Co-Development Agreement With Bristol-Myers Squibb | 15 | 1 |
| Adaptive Biotech Enters Into Co-Development Agreement With Bristol-Myers Squibb | 16 | 1 |
| Opko Health Expands Co-Development Agreement With Bristol-Myers Squibb For Alzheimer's Biomarkers | 17 | 1 |
| Life Technologies Enters Into Agreement With Bristol-Myers Squibb For Companion Diagnostics Development | 18 | 1 |
| Saladax Biomedical Expands Co-Development Agreement With Bristol-Myers Squibb | 19 | 1 |
| Bristol-Myers Squibb Enters Into Co-Development Agreement With Meso Scale | 20 | 1 |
| Dako Enters Into Co-Development Agreement With Bristol-Myers | 21 | 1 |
| Bristol-Myers Squibb, Saladax Biomedical And Ortho-Clinical Diagnostics Expand Co-Development Agreement | 22 | 2 |
| Opko Health Enters Into An Agreement With Bristol-Myers Squibb | 24 | 1 |
| Saladax Biomedical Enters Into Co-Development Agreement With Bristol-Myers Squibb | 25 | 1 |
| Debt Offering | 26 | 1 |
| Bristol-Myers Squibb Completes Public Offering Of Senior Unsecured Notes Due 2017 For US$750 Million | 26 | 2 |
| Bristol-Myers Squibb Completes Public Offering Of 2% Senior Unsecured Notes Due 2022 For US$750 Million | 28 | 2 |
| Bristol-Myers Squibb Completes Public Offering Of 3.25% Senior Unsecured Notes Due 2042 For US$500 Million | 30 | 2 |
| Acquisition | 32 | 1 |
| Bristol-Myers Rumored To Acquire Biogen Idec | 32 | 1 |
| Bristol-Myers Squibb Company - Key Competitors | 33 | 1 |
| Key Employees | 34 | 2 |
| Locations And Subsidiaries | 36 | 8 |
| Head Office | 36 | 1 |
| Other Locations &Subsidiaries | 36 | 8 |
| Recent Developments | 44 | 1 |
| Strategy And Business Planning | 44 | 1 |
| May 17, 2016: Bristol-Myers Squibb Opens Expanded Biologics Facility | 44 | 1 |
| Jun 25, 2015: Bristol-Myers Squibb Expands R&D Presence Within Hubs of World Class Science and Innovation | 45 | 1 |
| Financial Announcements | 46 | 1 |
| Jul 28, 2016: Bristol-Myers Squibb Reports Second Quarter Financial Results | 46 | 3 |
| Jan 28, 2016: Bristol-Myers Squibb Reports Fourth Quarter and Full Year 2015 Financial Results | 49 | 3 |
| Jul 23, 2015: Bristol-Myers Squibb Reports Second Quarter Financial Results | 52 | 3 |
| Corporate Communications | 55 | 1 |
| Jul 25, 2016: Bristol-Myers Squibb Appoints Fouad Namouni, M.D., Oncology Development Head | 55 | 1 |
| Jun 20, 2016: Murdo Gordon Appointed Executive Vice President and Chief Commercial Officer | 56 | 1 |
| Mar 03, 2016: Bristol-Myers Squibb Names Peter J. Arduini to Board of Directors | 57 | 1 |
| Legal and Regulatory | 58 | 1 |
| Apr 27, 2015: Bristol-Myers Squibb Receives Positive CHMP Opinion of New ORENCIA (abatacept) ClickJect Pre-Filled Pen Autoinjector Delivery Device | 58 | 1 |
| Other Significant Developments | 59 | 1 |
| May 19, 2016: Inovalon Announces Agreement with Bristol-Myers Squibb to Focus on Real World Outcomes &Value-Based Contracting Initiatives | 59 | 1 |
| Feb 03, 2016: Bonnie J. Addario Lung Cancer Foundation Honors Bristol-Myers Squibb for Improving and Advancing Breakthrough Treatments for Lung Cancer | 60 | 1 |
| Appendix | 61 | 1 |
| Methodology | 61 | 1 |
| About GlobalData | 61 | 1 |
| Contact Us | 61 | 1 |
| Disclaimer | 61 | 1 |